MENU
AMLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Amylyx Pharmaceuticals (AMLX) Ownership - Who owns Amylyx Pharmaceuticals?
Profile
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
286.53M
P/E Ratio
2.69
Total Cash
234.4M
Projected Growth
N/A
Total Debt
2.57M
Revenue
196.49M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.42
Total Debt/Equity
N/A
Revenue/Share
2.87 USD as % of share price
Fundamentals
AMLX
Capitalization
287M
P/E Ratio
2.69
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
234M
Total Cash/Share
3.42
Total Debt
2.57M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.87%
Revenue
196M
ROE
N/A
Book Value
196M
P/B Ratio
1.50
Cash Flow
N/A
Earnings
-3.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
4.55
Current Revenue Per Employee
1083.33
Dividends Per Share - Security
N/A
EBITDA
-212.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
-94.47
Revenue To Assets
-72.35
Shares Held By Institutions
183M
Shares Outstanding - Current
68.5M
Total Liabilities
54.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-70.924
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com